The evaluation of the efficacy and safety about apatinib combined with immune checkpoint inhibitors in advanced gastric cancer: a real-world study
Apatinib combined with ICIs demonstrated improved survival outcomes compared to apatinib monotherapy in AGC, particularly for patients with liver metastasis, without increasing severe toxicity.
Authors
- Pengfei Zhu (ORCID: https://orcid.org/0000-0001-7328-4161)
- Zheling Chen (ORCID: https://orcid.org/0000-0002-3073-1811)
- Liu Yang (ORCID: https://orcid.org/0000-0001-7587-312X)
Institutions
- Zhejiang Provincial People's Hospital (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-06-06
- DOI
- https://doi.org/10.3389/fonc.2025.1578011
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00